S4 + S23 + GW-501516 Value Pack

Buy S4 + S23 + GW-501516 Value Pack Online

This combination brings together two selective androgen receptor modulators — S4 and S23 — with GW-501516, a PPARδ agonist studied for metabolic and exercise-related pathways.

Product Information

S4 and S23 primarily interact with androgen-receptor pathways, while GW-501516 works through PPARδ. Research on the individual compounds has examined anabolic signaling, lipid metabolism, endurance, and endocrine effects.

How It Works

S4 and S23 activate androgen receptors, influencing androgen-responsive tissues. GW-501516 activates PPARδ, a receptor involved in fatty-acid oxidation and energy metabolism. The three compounds therefore act through distinct biological pathways.

POTENTIAL BENEFITS

1. Muscle Research

S4 and S23 have demonstrated anabolic activity in experimental models, making the combination relevant to research involving skeletal-muscle signaling.

2. Metabolic Research

GW-501516 has been shown to alter fatty-acid oxidation and metabolic gene expression through PPARδ activation.

3. Endurance Research

GW-501516 has produced increased running endurance and altered oxidative metabolism in animal studies, making it a notable research compound in exercise-metabolism research.

4. Androgen & Metabolic Pathways

The combination provides an experimental model involving both androgen-receptor signaling and metabolic pathways, allowing researchers to examine different physiological systems together.

Dosage

There is no established clinical dosage for this combination. The individual compounds have different pharmacological profiles, and online protocols should not be treated as validated combination dosing.

Side Effects

Potential concerns include hormonal suppression, lipid changes, endocrine effects, and metabolic reactions. GW-501516 has also raised significant long-term safety concerns in preclinical research.

References

• Thevis M, et al. Simultaneous detection of different chemical classes of selective androgen receptor modulators in urine. 2021. PubMed
• Anderson RA, et al. Preclinical assessment of S-23 for hormonal male contraception. PubMed
• Dressel U, et al. The PPARβ/δ agonist GW501516 regulates genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. PubMed
• Pokrywka A, et al. Metabolic modulators of the exercise response: doping control analysis of GW501516 and AICAR. 2014. PubMed

Reference note: These references support research on the individual compounds. They do not establish the safety or efficacy of the three-compound combination.

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to access instructions on how to make a payment.

How to Pay